Scaffold-free tissue-engineered cartilage grafts for nasal reconstructive surgery
Scaffold-free tissue-engineered cartilage grafts for nasal reconstructive surgery
批准号:
228632078
负责人:
Privatdozent Dr. Mark Jakob
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Fellowships
财政年份:
2012
资助国家:
德国
项目状态:
已结题
起止时间:
2011-12-31 至 2014-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Scaffold-free tissue-engineered cartilage grafts for nasal reconstructive surgery - Due to the low regeneration capacity of cartilage tissue, the treatment of cartilaginous malformations and damages represent a great challenge to the head and neck or maxillofacial surgeon. Tissue engineering research has opened up new perspectives for the treatment of cartilaginous defects in the head and neck area. With tissue engineering, it is potentially possible to grow sufficient cartilage of the septum or other cartilaginous parts of the nasal framework in the desired shape and size in vitro for use in surgical reconstructions. Tissue engineered grafts on different scaffolds caused a local foreign body reaction to the scaffold in vivo, which degraded the engineered cartilage. As a result of these findings it is useful to develop techniques for fabrication of cartilage grafts without the use of a scaffold in an effort to avoid the foreign body reaction. We assume that scaffold-free engineered sheets of cartilage can be used to fabricate an autologous neo-nasal cartilage graft in vitro with adequate mechanical integrity, ideal size, and form for nasal reconstructive surgery. Due to their chondrogenic differentiation potential in vitro, mesenchymal stem cells (MSCs) are considered an attractive alternative cell source for tissue engineering and treatment of nasal cartilage defects. MSCs may alleviate the problem of insufficient chondrocyte cell numbers or dedifferentiation during cell expansion, as they are able to both replicate themselves and differentiate in response to a variety of growth factors. Therefore, we will investigate the cross talk between human bone-marrow mesenchymal stem cells (bmMSCs) and human chondrocytes in an in vitro co-culture system.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
一次扫描多对比度及free-water DTI技术在功能区脑肿瘤中的研究
-
批准号:JCZRLH202500011
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
基于碳纳米管技术和转座子开发一种新型的、
marker-free 的植物转基因技术
-
批准号:Z24C160005
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:周明兵
-
依托单位:
面向Cell-Free网络的协同虚拟化与动态传输
-
批准号:62371367
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈健
-
依托单位:
基于Lab-free电化学发光平台的ctDNA甲基化分析研究
-
批准号:22374123
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:卓颖
-
依托单位:
基于制备内源5mc-free基因组的策略鉴定新型DNA修饰并解析其产生机理
-
批准号:32370576
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:陈辉
-
依托单位:
基于定点突变膜受体Cell-free合成生物色谱新方法的PDGFRβ抑制剂筛选和结合位点分析
-
批准号:82273886
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:原永芳
-
依托单位:
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:杨胜彩
-
依托单位:
利用CRISPR/Cas RNP介导的DNA-free基因编辑衣藻控制登革热传播媒介伊蚊
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:35万元
-
批准年份:2022
-
负责人:费小雯
-
依托单位:
番茄基于DNA-free基因编辑技术的2种类病毒抑制和脱毒的机理研究
-
批准号:32102396
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:李经纬
-
依托单位:
低损耗snapback-free RC LIGBT机理与新结构研究
-
批准号:62104030
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2021
-
负责人:杨可萌
-
依托单位: